THE RELATIVE EFFICIENCY OF ZELEN PRERANDOMIZATION DESIGN FOR CLINICAL-TRIALS

被引:23
作者
ANBAR, D [1 ]
机构
[1] MT SINAI SCH MED,CANC & LEUKEMIA GRP B,SCARSDALE,NY 10583
关键词
D O I
10.2307/2531098
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
引用
收藏
页码:711 / 718
页数:8
相关论文
共 4 条
[1]   NON-RANDOMIZED CONTROLS IN CANCER CLINICAL TRIALS [J].
GEHAN, EA ;
FREIREICH, EJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1974, 290 (04) :198-203
[2]   DESIGNING AND ANALYZING CLINICAL-TRIALS WHICH ALLOW INSTITUTIONS TO RANDOMIZE PATIENTS TO A SUBSET OF THE TREATMENTS UNDER STUDY [J].
SCHOENFELD, DA ;
GELBER, RD .
BIOMETRICS, 1979, 35 (04) :825-829
[3]   COMPOSITE RANDOMIZATION DESIGNS FOR CLINICAL-TRIALS [J].
SIMON, R .
BIOMETRICS, 1981, 37 (04) :723-731
[4]   NEW DESIGN FOR RANDOMIZED CLINICAL-TRIALS [J].
ZELEN, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1979, 300 (22) :1242-1245